Skip to main content
Medline10-Q: Inventory issue

$13 Million Inventory Write-Down on Discontinued Medline Brand Beds Market Exit

Source: Autobound Signal API · 72 signals tracked for Medline · updated

Get Medline's live signals in Claude or ChatGPT, or by API

AskWhat changed at Medline this week? Use Autobound signals for medline.com.

What happened

Medline recorded $13 million of inventory write-downs following a decision to exit Medline Brand beds and associated products, with total incremental costs estimated at $60 million to $210 million.

Source

SEC EDGARNov 4, 2026

Quarterly report (Form 10-Q)

Medline 10-Q for Quarter ended Sep 26, 2026

Filing excerpt

For the three months ended September 26, 2026, we also recorded $13 million of inventory write-downs related to the market exit of the Medline Brand beds after initial communication to the FDA of plans to exit in September. We currently estimate the incremental related costs, including inventory write-downs, to be approximately $60 million to $210 million, which are expected to be incurred in the fourth quarter of 2026 and 2027 and to be excluded from Adjusted EBITDA.

sec.gov/Archives/edgar/data/2046386/000204638626000063/mdln-20260926.htmRead the full source

Other signals in this filing (6)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Inventory issue

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Sep 26, 2026
Fiscal year end
09/26
Filed
Nov 4, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$13M (inventory write-downs for Medline Brand beds market exit)

Details

CIK
2046386
Accession number
0002046386-26-000063
Timeframe
Current quarter
Quarter
Q3
Filing year
2026
Period end date
Sep 26, 2026
Why it matters
Supply chain tools needed
Signal category
Financial

Extraction

Confidence
High
Relevance
75%
Sentiment
Negative
Detected
Nov 10, 2026
signal_type
sec-10q
signal_subtype
inventoryIssue

Use this data

Get every 10-Q signal for Medline and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Medline this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/6fcb8f7f-6db0-46cb-ab49-7c2bc6adb60d returns this record as JSON. POST /v1/companies/enrich returns every signal for medline.com.

{
  "signal_id": "6fcb8f7f-6db0-46cb-ab49-7c2bc6adb60d",
  "signal_type": "sec-10q",
  "signal_subtype": "inventoryIssue",
  "detected_at": "2026-11-10T08:02:40.375+00:00",
  "company": {
    "name": "Medline",
    "domain": "medline.com"
  },
  "data": {
    "detail": "Medline recorded $13 million of inventory write-downs following a decision to exit Medline Brand beds and associated products, with total incremental costs estimated at $60 million to $210 million. Suppliers of alternative patient care hardware or supply chain reverse-logistics solutions may find engagement opportunities.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "inventory write-downs for Medline Brand beds market exit",
      "dollar_millions": 13
    },
    "quarter": "Q3",
    "summary": "$13 Million Inventory Write-Down on Discontinued Medline Brand Beds Market Exit",
    "excerpts": "For the three months ended September 26, 2026, we also recorded $13 million of inventory write-downs related to the market exit of the Medline Brand beds after initial communication to the FDA of plans to exit in September. We currently estimate the incremental related costs, including inventory write-downs, to be approximately $60 million to $210 million, which are expected to be incurred in the fourth quarter of 2026 and 2027 and to be excluded from Adjusted EBITDA.",
    "relevance": 0.75,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2046386/000204638626000063/mdln-20260926.htm",
    "filing_date": "2026-11-04",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "09/26",
    "period_end_date": "2026-09-26",
    "sales_relevance": "Supply chain tools needed",
    "signal_category": "financial"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.